CN103041290B - Traditional Chinese medicine for treating lung cancer - Google Patents

Traditional Chinese medicine for treating lung cancer Download PDF

Info

Publication number
CN103041290B
CN103041290B CN201210497688.XA CN201210497688A CN103041290B CN 103041290 B CN103041290 B CN 103041290B CN 201210497688 A CN201210497688 A CN 201210497688A CN 103041290 B CN103041290 B CN 103041290B
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210497688.XA
Other languages
Chinese (zh)
Other versions
CN103041290A (en
Inventor
潘万刚
邱美华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NINGBO TCM CANCER HOSPITAL
Original Assignee
NINGBO TCM CANCER HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGBO TCM CANCER HOSPITAL filed Critical NINGBO TCM CANCER HOSPITAL
Priority to CN201210497688.XA priority Critical patent/CN103041290B/en
Publication of CN103041290A publication Critical patent/CN103041290A/en
Application granted granted Critical
Publication of CN103041290B publication Critical patent/CN103041290B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating lung cancer. The traditional Chinese medicine comprises the following material components in parts by weight: 4-8 parts of oldenlandia diffusa, 1-3 parts of Chinese blister beetles roasted with vinegar, 2-6 parts of aspongopus, 18-22 parts of long-noded pit vipers, 23-27 parts of salvia chinensis, 6-10 parts of radix curcumae, 14-18 parts of phyllanthus ruinaria, 6-10 parts of scutellariae barbatae, 1-3 parts of earwis, 28-32 parts of hulls of water chestnuts, 10-14 parts of leeches, 6-10 parts of stephania sinica diels, 2-6 parts of white glues and 1-5 parts of rabdosia japonica. The health, the appetite and the immunity of the patient can be remarkably strengthened by taking the traditional Chinese medicine disclosed by the invention; the cancer cell lesion can be restrained and prevented by taking the medicine for a long time. Besides, the medicine has no toxic and side effect, as well as a better effect for a use after the operation.

Description

A kind of Chinese medicine of Hepatoma therapy
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine of Hepatoma therapy.
background technology:
Day by day serious along with environmental pollution, people are subject to the factors such as chemistry, physics, biology (as smoking, excessive drinking, ionizing radiation and air pollution etc.), and the sickness rate of cancer is more and more higher, and wherein hepatocarcinoma is that China head sees one of malignant tumor.Mortality rate is high, is only second to gastric cancer, esophageal carcinoma and occupies the 3rd in mortality of malignant tumors cis-position, accounts for second in the rural area in area, position.Modern medicine mainly adopts operation, radiation and chemotherapy for the treatment of cancer, but the equal defectiveness of these methods, wherein only have early stage patient just can carry out operative treatment, the means of topical therapeutic during operative treatment, like water off a duck's back for the tumor cell of transferring in blood or its hetero-organization, Radiotherapy chemotherapy can effectively be hindered cancerous cell, but the while can be killed and wounded normal cell again and cause patient's immunologic function suppressed, there is more complication, to patient body, bring very big damage.Also there is now the Chinese medicine of some Hepatoma therapies, but be all to take pain relieving, relief of symptoms as main, can not play actual antitumaous effect.
summary of the invention:
The object of the invention is exactly in order to make up the defect of prior art, and a kind of Chinese medicine of Hepatoma therapy is provided, and can suppress and prevent cancerous cell pathological changes.
The present invention is achieved by the following technical solutions:
A Chinese medicine for Hepatoma therapy, is characterized in that: the weight proportion of its each raw material components is: Herba Hedyotidis Diffusae 4-8, vinegar stir-baked MYLABRIS with rice 1-3, Aspongopus 2-6, Agkistrodon 18-22, Herba Salviae Chinensis 23-27, Radix Curcumae 6-10, Radix Ginseng 2-6, Semen Persicae 6-10, Cacumen Securinegae Suffruticosae 14-18, Herba Scutellariae Barbatae 6-10, Toreia concolor Lindley Var formosans yamazaki 1-3, Shell of Water Chestnut 28-32, Hirudo 10-14, Radix Rumicis Crispi 6-10, Resina Liquidambaris 2-6, Rabdosia japonica 1-5.
A Chinese medicine for Hepatoma therapy, is characterized in that: the weight proportion of its each raw material components is: Herba Hedyotidis Diffusae 6, vinegar stir-baked MYLABRIS with rice 2, Aspongopus 4, Agkistrodon 20, Herba Salviae Chinensis 25, Radix Curcumae 8, Radix Ginseng 4, Semen Persicae 8, Cacumen Securinegae Suffruticosae 16, Herba Scutellariae Barbatae 8, Toreia concolor Lindley Var formosans yamazaki 2, Shell of Water Chestnut 30, Hirudo 12, Radix Rumicis Crispi 8, Resina Liquidambaris 4, Rabdosia japonica 3.
Advantage of the present invention is:
Take Chinese medicine of the present invention and can obviously strengthen patient's body constitution, strengthen patient's appetite, strengthen patient's resistance, long-term taking can suppress and prevent cancerous cell pathological changes, has no side effect, and coordinates postoperative use, and effect is better.
the specific embodiment:
A Chinese medicine for Hepatoma therapy, the weight of its each raw material components (g) is: Herba Hedyotidis Diffusae 6, vinegar stir-baked MYLABRIS with rice 2, Aspongopus 4, Agkistrodon 20, Herba Salviae Chinensis 25, Radix Curcumae 8, Radix Ginseng 4, Semen Persicae 8, Cacumen Securinegae Suffruticosae 16, Herba Scutellariae Barbatae 8, Toreia concolor Lindley Var formosans yamazaki 2, Shell of Water Chestnut 30, Hirudo 12, Radix Rumicis Crispi 8, Resina Liquidambaris 4, Rabdosia japonica 3.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proof, the present invention has good curative effect, enumerates model case as follows:
Case one:
Grandson, man, 48 years old.Main suit: epigastrium dull pain is uncomfortable, become thin, liver pain, epigastrium are laid one's hand on enclosed mass 15 days, alpha-fetoprotein (AFP) 12500ng, B ultrasonic, CT examination show " left liver occupy-place ", on May 21st, 2004, are in hospital.June 12, operation, was shown in micronodular cirrhosis in art, and tumor is positioned at left half intrahepatic leaf, and approximately 5 * 6cm size, goes " left intrahepatic leaf excision ".Postoperatively give Chinese medicine of the present invention and take, after three months, AFP is down to normally, and life work is as usual, strong depositing so far.
Case two:
Zhao, man, 56 years old.Main suit: before three months, liver pain is uncomfortable, appetite declines, becomes thin, and B ultrasonic, CT examination are found " right liver occupy-place ", is in hospital in December in 2007 on the 6th.Same month 26 operation, is shown in micronodular cirrhosis in art, tumor is positioned at right liver upper back, and approximately 4 * 6cm size, goes " epimere excision after right liver ".Pathological replacement is: " hepatocellular carcinoma ".Postoperatively give Chinese medicine of the present invention and take, after four months, AFP is down to normally, Return to work, strong depositing so far.
Case three:
Wang, man, 59 years old.Main suit: the uncomfortable companion of upper right abdomen dull pain general weakness 2 months, AFP46.6ng, B ultrasonic, CT examination are found " right liver occupy-place ", on May 10th, 2007, are in hospital.Operation in of that month 23 days, is shown in art that tumor is positioned at right liver caudal lobe, and approximately 3 * 4cm, near right portal vein trunk and postcava trunk, goes " right liver bottom part+right liver resection of caudate lobe ".Pathological replacement is: " hepatocellular carcinoma ".Postoperatively give Chinese medicine of the present invention and take, after five months, AFP is down to normally, lives as usual, strong depositing so far.

Claims (1)

1. a Chinese medicine for Hepatoma therapy, is characterized in that: the weight proportion of its each raw material components is: Herba Hedyotidis Diffusae 6, vinegar stir-baked MYLABRIS with rice 2, Aspongopus 4, Agkistrodon 20, Herba Salviae Chinensis 25, Radix Curcumae 8, Radix Ginseng 4, Semen Persicae 8, Cacumen Securinegae Suffruticosae 16, Herba Scutellariae Barbatae 8, Toreia concolor Lindley Var formosans yamazaki 2, Shell of Water Chestnut 30, Hirudo 12, Radix Rumicis Crispi 8, Resina Liquidambaris 4, Rabdosia japonica 3.
CN201210497688.XA 2012-11-29 2012-11-29 Traditional Chinese medicine for treating lung cancer Expired - Fee Related CN103041290B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210497688.XA CN103041290B (en) 2012-11-29 2012-11-29 Traditional Chinese medicine for treating lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210497688.XA CN103041290B (en) 2012-11-29 2012-11-29 Traditional Chinese medicine for treating lung cancer

Publications (2)

Publication Number Publication Date
CN103041290A CN103041290A (en) 2013-04-17
CN103041290B true CN103041290B (en) 2014-04-09

Family

ID=48054301

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210497688.XA Expired - Fee Related CN103041290B (en) 2012-11-29 2012-11-29 Traditional Chinese medicine for treating lung cancer

Country Status (1)

Country Link
CN (1) CN103041290B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104491712A (en) * 2014-12-09 2015-04-08 高炜 Traditional Chinese medicine formula for treating liver cancer, and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN101693097A (en) * 2009-10-22 2010-04-14 广西医科大学附属肿瘤医院 Medicament for adjuvant therapy of tumors and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101670071A (en) * 2009-09-25 2010-03-17 卢速江 Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN101693097A (en) * 2009-10-22 2010-04-14 广西医科大学附属肿瘤医院 Medicament for adjuvant therapy of tumors and preparation method thereof

Also Published As

Publication number Publication date
CN103041290A (en) 2013-04-17

Similar Documents

Publication Publication Date Title
CN102716351A (en) Traditional Chinese medicine electuary for clearing heat and reducing fever
CN103041290B (en) Traditional Chinese medicine for treating lung cancer
CN105456428A (en) Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof
CN103041041B (en) Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer
CN103585364A (en) Traditional Chinese medicine formula for treating intestinal cancer
CN103372083A (en) Chinese medicinal composition for treating spontaneous perspiration
CN103071112B (en) Traditional Chinese medicine for curing nasopharynx cancer
CN102441137A (en) Chinese medicine composition for resisting tumour
CN106266592A (en) A kind of Chinese caterpillar fungus health-care product containing Chinese medicine extract and preparation method thereof
CN102266470A (en) Traditional Chinese medicine composition for treating insomnia
CN104107414A (en) Medicine for treating esophagus cancer disease and production method thereof
CN104116956A (en) Pharmaceutical composition for treating cancer pain in anesthesia department
CN104522246A (en) Artocarpus lingnanensis root liver protection tea
CN104147149A (en) Traditional Chinese medicine for treating heart-yang deficiency type ventricular arrhythmias
CN103768718A (en) Far infrared magnet therapy paster for treating tumor
CN103800587A (en) Traditional Chinese medicine composition for treating lung cancer
CN103571700A (en) Cordyceps militaris health wine
CN103830597A (en) Formula for treating hidrosis of children
CN103623270B (en) A kind of Chinese medicine for the treatment of spleen deficiency type fever
CN102406873A (en) Traditional Chinese medicine injection for treating gastric cancer
CN106309759A (en) Traditional Chinese medicine composition for treating liver cancer
CN104800693B (en) A kind of Chinese medicine composition for treating lung cancer
CN104189423A (en) Traditional Chinese medicine decoction for treating gastric cancer
CN105012913A (en) Drug for treating cold cough and preparation method of drug
CN103805416A (en) Traditional Chinese medicine tonic containing Chinese yam

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140409

Termination date: 20151129

CF01 Termination of patent right due to non-payment of annual fee